Pathways to reduce diabetic ketoacidosis with new onset type 1 diabetes: Evidence from a regional pediatric diabetes center: Auckland, New Zealand, 2010 to 2014

Pediatr Diabetes. 2017 Nov;18(7):553-558. doi: 10.1111/pedi.12456. Epub 2016 Oct 11.

Abstract

Background: There has been little change in the incidence of diabetic ketoacidosis (DKA) in newly diagnosed type 1 diabetes mellitus (T1DM) in children and adolescents in most developed countries.

Objectives: To assess potentially modifiable antecedents of DKA in children <15 years of age with new onset T1DM.

Methods: Retrospective review of prospectively collected data from a complete regional cohort of children with T1DM in Auckland (New Zealand) from 2010 to 2014. DKA and severity were defined according to the ISPAD 2014 guidelines.

Results: A total of 263 children presented with new onset T1DM during the 5-year study period at 9.0 years of age (range 1.0-14.7), of whom 61% were NZ-European, 14% Maori, 13% Pacifica, and 11% other. A total of 71 patients (27%) were in DKA, including 31 mild, 20 moderate, and 20 severe DKA. DKA was associated with no family history of T1DM, higher glycated hemoglobin (HbA1c) values at presentation, self-presenting to secondary care, health care professional contacts in the 4 weeks before final presentation, and greater deprivation. Although a delay in referral from primary care for laboratory testing was common (81/216), only delay for more than 48 hours was associated with increased risk of DKA (11/22 > 48 h vs 12/59 referred at <48 h, P = .013).

Conclusions: These data suggest that in addition to lack of family awareness potentially modifiable risk factors for new onset DKA include prolonged delay for laboratory testing and a low index of medical suspicion for T1DM leading to delayed diagnosis.

Keywords: T1DM; children; diabetic ketoacidosis; insulin.

MeSH terms

  • Adolescent
  • Blood Glucose / analysis
  • Child
  • Child, Preschool
  • Cohort Studies
  • Combined Modality Therapy
  • Delayed Diagnosis
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / diagnosis*
  • Diabetes Mellitus, Type 1 / therapy
  • Diabetes Mellitus, Type 1 / urine
  • Diabetic Ketoacidosis / epidemiology
  • Diabetic Ketoacidosis / prevention & control*
  • Family
  • Female
  • Glycosuria / epidemiology
  • Glycosuria / prevention & control
  • Health Knowledge, Attitudes, Practice
  • Hospitals, Pediatric
  • Humans
  • Male
  • Medical Audit
  • New Zealand / epidemiology
  • Referral and Consultation
  • Regional Medical Programs
  • Retrospective Studies
  • Risk

Substances

  • Blood Glucose